Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-TNF therapy and susceptibility to Coxiella burnetii infection
NL-OMON35680Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2011
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label trial of infliximab, etanercept and adalimumab in Q fever, sponsored by Radboud University Medical Center. Started Dec 2011; status: active, not recruiting.
02
Drugs
03
Conditions
Q fever
Beyond the preview
Go deeper on NL-OMON35680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35680.